pyruvaldehyde has been researched along with monascin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YY; Hsu, WH; Hsu, YW; Huang, T; Lee, BH; Pan, TM | 1 |
| Hsu, WH; Hsu, YW; Lee, BH; Li, CH; Pan, TM | 1 |
| Chang, YY; Hsu, WH; Hsu, YW; Lee, BH; Pan, TM | 1 |
3 other study(ies) available for pyruvaldehyde and monascin
| Article | Year |
|---|---|
Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated wistar rats.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Humans; Male; Monocytes; NF-E2-Related Factor 2; Pyruvaldehyde; Rats; Rats, Wistar; Up-Regulation | 2013 |
Monascin and AITC attenuate methylglyoxal-induced PPARĪ³ phosphorylation and degradation through inhibition of the oxidative stress/PKC pathway depending on Nrf2 activation.
Topics: Animals; Heterocyclic Compounds, 3-Ring; Isothiocyanates; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; PPAR gamma; Protein Kinase C; Proteolysis; Pyruvaldehyde | 2013 |
A novel natural Nrf2 activator with PPARĪ³-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia.
Topics: Animals; Dose-Response Relationship, Drug; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Hyperglycemia; Male; NF-E2-Related Factor 2; PPAR gamma; Pyruvaldehyde; Rats; Rats, Wistar | 2013 |